1. Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets – Beyond B Lymphocytes
    Sining Zhu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  2. Differential impact of BTK active site inhibitors on the conformational state of full-length BTK
    Raji E Joseph et al, 2020, eLife CrossRef
  3. Chronic Lymphocytic Leukemia Causing Gastric Ulcer Perforation: A Case Presentation and Literature Review
    Ariana R Tagliaferri et al, 2023, Cureus CrossRef
  4. Rituximab combined with Bruton tyrosine kinase inhibitor to treat elderly diffuse large B-cell lymphoma patients: Two case reports
    Cang-Jian Zhang et al, 2023, World Journal of Clinical Cases CrossRef
  5. Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study
    Veronica Mattiello et al, 2023, Hematological Oncology CrossRef
  6. Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures
    Garth E. Ringheim et al, 2021, Frontiers in Immunology CrossRef